Psilera
Tampa, US · Founded 2021 · Florida corporation · 3 known investors
Find your way into Psilera
2,003 people in our graph share verified history with the Psilera team — schools, employers, funds. One of them is your warm intro.
Kyle Dohertyunlockedknows Scott Rairigh · together at Harvard Business School (overlapped)
×11knows the team · via Harvard Business School
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
Founders & leadership
Psilera was founded in 2021 by Jacqueline Lee Salm, Jackie von Salm, and Chris Witowski.
JL
Jacqueline Lee SalmCo-founder
JV
Jackie von SalminCo-Founder & Chief Scientific OfficerJackie von Salm is a natural products chemist with postdoctoral training in metabolomics and antibiotics research. As Co-founder and Chief Scientific Officer of Psilera, a biotech company developing neuroscience-focused therapeutics, von Salm has focused on the therapeutic applications of psychoactive natural substances for mental health and neurological disorders.
CW
Chris WitowskiinCo-Founder & CEODr. Witowski is a chemist with 15 years of drug discovery experience and 8+ years in CNS-focused leadership roles; he previously led operations at AltMed and holds 10+ patents. He co-founded Psilera in 2019, a biotech company developing serotonergic therapeutics for psychiatric and neurodegenerative disorders.
SR
Scott RairighinExecutive Vice President Corporate DevelopmentScott Rairigh held leadership roles in diagnostics and precision medicine commercialization across multiple pharmaceutical and diagnostics companies, including BMS (formerly Celgene), Janssen, Roche Diagnostics, and Ortho Clinical Diagnostics, where he drove revenue growth in immunodiagnostics and molecular diagnostics. He also led business development at Virco, scaling its HIV resistance testing business and acquiring LabTracker Software.
MH
Magali HaasinChief Medical Officer
Investors · 3
Funding
SEC filings, press & company announcements$11.3M disclosed across 2 of 3 rounds · 2021–2026
- $8.8MSeedMay 2026 · 2 sourcesSource ↗
▶$2.5MraisedAug 2021 · 14 investors · BiotechnologyRule 506(b)
▶$2.5MraisedAug 2021 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott RairighDirector
- Jacqueline Lee SalmExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $50K
- Proceeds to insiders
- $180K
- First sale
- Jul 2021
- Incorporated
- Corporation, Florida, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, as Vice President, Clinical Development to Lead Upcoming Phase 1 Clinical Trialprnewswire.com · Aug 2026Frequently asked questions
- What does Psilera do?
- Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
- Who founded Psilera?
- Psilera was founded by Jacqueline Lee Salm, Jackie von Salm, Chris Witowski in 2021.
- Who are Psilera's investors?
- Psilera's investors include Bonaventure Equity, LLC, Iter Investments, Mystic Ventures.
- How much funding has Psilera raised?
- Psilera has disclosed $11.3M raised across 2 of its 3 known rounds.
- Where is Psilera headquartered?
- Psilera is headquartered in Tampa, US.